Cargando…
可切除Ⅲa/N2期非小细胞肺癌治疗模式探讨
Standard treatment for resectable Ⅲa/N2 non-small-cell lung cancer (NSCLC) is still under debate. Optional treatments include chemotherapy, radiotherapy and surgery, other options include target therapy and immunotherapy. Multidisciplinary treatment has therefore been emphasized by various clinical...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397938/ https://www.ncbi.nlm.nih.gov/pubmed/30827328 http://dx.doi.org/10.3779/j.issn.1009-3419.2019.02.06 |